3,194
Views
52
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: ELDERLY PATIENTS

Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer

ORCID Icon, , , , , , , ORCID Icon, , & show all
Pages 1475-1481 | Received 02 Nov 2017, Accepted 30 May 2018, Published online: 01 Aug 2018

References

  • Sjoquist KM, Burmeister BH, Smithers BM. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–692.
  • Mukherjee S, Nicholas C, Gwynne S, et al. NEOSCOPE: a randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. Eur J Cancer. 2017;74:38–46.
  • van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084.
  • Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–1098.
  • Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v50–v57.
  • Noordman BJ, Shapiro J, Spaander MC, et al. Accuracy of detecting residual disease after CROSS neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol. JMIR Res Protoc. 2015;4:e79.
  • Lambin P, Zindler J, Vanneste B, et al. Modern clinical research: how rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine. Acta Oncol. 2015;54:1289–1300.
  • Lambin P, Zindler J, Vanneste BGL, et al. Decision support systems for personalized and participative radiation oncology. Adv Drug Deliv Rev. 2017;109:131–153.
  • Lambin P, van Stiphout RGPM, Starmans MHW, et al. Predicting outcomes in radiation oncology - multifactorial decision support systems. Nat Rev Clin Oncol. 2013;10:27–40.
  • Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441–446.
  • Aerts HJWL, Velazquez ER, Leijenaar RTH, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.
  • Leijenaar RTH, Carvalho S, Hoebers FJP, et al. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol. 2015;54:1423–1429.
  • Coroller TP, Grossmann P, Hou Y, et al. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol. 2015;114:345–350.
  • Ganeshan B, Skogen K, Pressney I, et al. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol. 2012;67:157–164.
  • Yip C, Davnall F, Kozarski R, et al. Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus. 2015;28:172–179.
  • Yip C, Landau D, Kozarski R, et al. Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. Radiology 2014;270:141–148.
  • Larue RTHM, van Timmeren JE, de Jong EEC, et al. Influence of grey level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study. Acta Oncol. 2017;56:1544–1553.
  • Haralick RM, Shanmugam K, Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybern. 1973;SMC-3:610–621.
  • Thibault G, Angulo J, Meyer F. Advanced statistical matrices for texture characterization: application to cell classification. IEEE Trans Biomed Eng. 2014;61:630–637.
  • Galloway MM. Texture analysis using gray level run lengths. Comput Graph Image Process. 1975;4:172–179.
  • Thibault G, Fertil B, Navarro C. Texture indexes and gray level size zone matrix application to cell nuclei classification. 10th International Conference on Pattern Recognition and Information Processing; Minsk, Belarus; 2009; p. 140–145.
  • Sun C, Wee WG. Neighboring grey level dependence matrix for texture classification. Comput Graph Image Process. 1983;23:341–352.
  • Amadasun M, King R. Textural features corresponding to textural properties. IEEE Trans Syst Man Cybern. 1989;19:1264–1274.
  • Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–762.
  • Kuhn M. Building predictive models in R using the caret package. J Stat Soft. 2008;28: 1–26.
  • Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2:18–22.
  • Mandard A-M, Dalibard F, Mandard J-C, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of eophageal carcinoma. Cancer. 1994;73:2680–2686.
  • Toxopeus ELA, Nieboer D, Shapiro J, et al. Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer. Radiother Oncol. 2015;115:392–398.
  • Tomasello G, Petrelli F, Ghidini M, et al. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: a meta-analysis of 17 published studies. Eur J Surg Oncol. 2017;43:1607–1616.
  • Chao Y-K, Chuang W-Y, Chang H-K, et al. Prognosis of patients with esophageal squamous cell carcinoma who achieve major histopathological response after neoadjuvant chemoradiotherapy. Eur J Surg Oncol. 2017;43:234–239.
  • Cao J, Yuan P, Wang L, et al. Clinical nomogram for predicting survival of esophageal cancer patients after esophagectomy. Sci Rep. 2016;6:26684.
  • Mackin D, Fave X, Zhang L, et al. Measuring computed tomography scanner variability of radiomics features. Invest Radiol. 2015;50:757–765.
  • Shafiq-ul-Hassan M, Zhang GG, Latifi K, et al. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys. 2017;44:1050–1062.
  • Huang Z, Ma L, Huang C, et al. Proteomic profiling of human plasma for cancer biomarker discovery. Proteomics. 2017;17:1600240.
  • The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541:169–175.
  • O’Connor JPB, Aboagye EO, Adams JE, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169–186.
  • Parmar C, Rios Velazquez E, Leijenaar R, et al. Robust radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One. 2014;9:e102107.
  • Leijenaar RTH, Carvalho S, Velazquez ER, et al. Stability of FDG-PET radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol. 2013;52:1391–1397.